Comparison of the therapeutic effect of intralesional injection of botulinum toxin with placebo in patients with androgenetic alopecia receiving finasteride tab

Phase 3

Recruiting

• Conditions: male androgenetic alopecia.; Androgenic alopecia

• Registration Number: IRCT20191013045092N3
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 48

Inclusion Criteria

1. Being male and older than 18 years 2. Suffering from androgenic alopecia grade 3 to 5 based on the Norwood Hamilton classification and Not receiving treatment for androgenic alopecia during the last 3 months

Exclusion Criteria

1. Severe diseases of internal organs, eyes or skin 2. Diseases of the neuromuscular system 3. Inflammation, infection or unhealed wounds on the skin around the injection site on the head 4. Receiving systematic treatment with corticosteroids or other immunosuppressants and immune modulators in the last 3 months 5. Receiving anticoagulant and antiplatelet drugs 6. Hair transplantation in the past 7. Infectious underlying disease, autoimmune, malignancy 8. Phobia about treatment with botulinum toxin 9. Reluctance to continue Study participation during treatment and follow-up

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hair density. Timepoint: Measurement of hair density at the beginning of the study and at the end of month 3 and at the end of month 6. Method of measurement: Photographing with a visioface 1000 D device.